{"id":172227,"date":"2015-01-06T14:48:04","date_gmt":"2015-01-06T19:48:04","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/first-human-trial-of-new-experimental-ebola-vaccine-begin.php"},"modified":"2015-01-06T14:48:04","modified_gmt":"2015-01-06T19:48:04","slug":"first-human-trial-of-new-experimental-ebola-vaccine-begin","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-genetics\/first-human-trial-of-new-experimental-ebola-vaccine-begin.php","title":{"rendered":"First human trial of new experimental Ebola vaccine begin"},"content":{"rendered":"<p><p>Oxford University scientists begin to immunise      volunteers              Hope to immunise 72 adults by the end of the      month to trial the new jab              A prime injection is followed by a booster to      strengthen immune response              The vaccine      wassuccessfulin      protecting primates against Ebola              There are now at least three Ebola vaccines being      trialled for safety        <\/p>\n<p>    By Madlen Davies for MailOnline  <\/p>\n<p>    Published: 10:08 EST, 6    January 2015 | Updated: 12:54 EST, 6 January    2015  <\/p>\n<p>    The first human trials of a new Ebola vaccine are today    underway, the latest step in attempts to halt the spread of the    virus in West Africa.  <\/p>\n<p>    Scientists at Oxford University have immunised the first    healthy volunteers with a new drug, which they hope will    protect people against the disease.  <\/p>\n<p>    The World Health Organisation said today more than 8,100    people have now lost their lives to the virus, the majority in    Guinea, Sierra Leone and Liberia.  <\/p>\n<p>    In September a separate trial was launched at the    university, to test the effects of another potential    vaccine.  <\/p>\n<p>    The Oxford Vaccine Group, part of the University of    Oxford Department of Paediatrics, aims to have vaccinated 72    healthy adult volunteers by the end of this month.  <\/p>\n<p>      Oxford University scientists have begun immunising healthy      volunteers in a trial of a new experimental Ebola vaccine.      They hope to immunise 72 adults by the end of the month    <\/p>\n<p>    The study involves a 'prime-boost' vaccine regime,    meaning volunteers are given a first 'prime' injection to    stimulate an initial immune response.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See more here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.dailymail.co.uk\/health\/article-2898965\/First-human-trial-new-experimental-Ebola-vaccine-begins-bid-halt-epidemic-death-toll-exceeds-8-000.html?ITO=1490&ns_mchannel=rss&ns_campaign=1490\/RK=0\/RS=54s3iNH96b5AD4AF9BfE4RM1UT0-\" title=\"First human trial of new experimental Ebola vaccine begin\">First human trial of new experimental Ebola vaccine begin<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Oxford University scientists begin to immunise volunteers Hope to immunise 72 adults by the end of the month to trial the new jab A prime injection is followed by a booster to strengthen immune response The vaccine wassuccessfulin protecting primates against Ebola There are now at least three Ebola vaccines being trialled for safety By Madlen Davies for MailOnline Published: 10:08 EST, 6 January 2015 | Updated: 12:54 EST, 6 January 2015 The first human trials of a new Ebola vaccine are today underway, the latest step in attempts to halt the spread of the virus in West Africa. Scientists at Oxford University have immunised the first healthy volunteers with a new drug, which they hope will protect people against the disease. The World Health Organisation said today more than 8,100 people have now lost their lives to the virus, the majority in Guinea, Sierra Leone and Liberia.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-genetics\/first-human-trial-of-new-experimental-ebola-vaccine-begin.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-172227","post","type-post","status-publish","format-standard","hentry","category-human-genetics"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/172227"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=172227"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/172227\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=172227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=172227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=172227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}